New and Emerging Treatments for Rosacea

Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial

(2015) A. Taieb et al.   BRITISH JOURNAL OF DERMATOLOGY

Rosacea

(2015) Aimee M. Two et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The psychological impact of rosacea and the influence of current management options

(2014) Farah Moustafa et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Emerging therapies in rosacea

(2013) Alison Layton et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin

(2012) Kimberly N. Kanada et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Clinical, Cellular, and Molecular Aspects in the Pathophysiology of Rosacea

(2011) Martin Steinhoff et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS

Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway

(2009) Xinxin Ci et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY